<div id="readability-page-1"><div><h2>What recent performance says about Herbalife stock</h2> <p>Herbalife (HLF) has drawn fresh attention after a strong run, with the share price at $19.96 and total return figures of 20% over the past month and 67% over the past 3 months.</p> <p>For longer term holders, the stock shows a 56% decline over 5 years, alongside a 140% total return over the past year and a modest 2% total return over 3 years. This highlights mixed holding period experiences.</p> <p>See our latest analysis for Herbalife.</p> <p>The recent surge in Herbalife’s share price, including a 25.53% 7 day share price return and 55.69% year to date share price return at a last close of $19.96, points to building momentum after a weak multi year total shareholder return. In the short term, the market appears more willing to price in potential upside or lower perceived risk, even as the 5 year total shareholder return of 55.62% decline keeps the longer term record muted.</p> <p>If Herbalife’s rebound has you looking beyond a single name, it could be a good moment to broaden your search with our screener of 22 top founder-led companies.</p> <p>So, with Herbalife trading at $19.96, a value score of 5, an intrinsic discount of 35.54%, and a price target of $16.50, is the rebound signaling an undervalued setup, or has the market already priced in future growth?</p> <h2>Most Popular Narrative: 43% Overvalued</h2> <p>Herbalife’s most followed narrative pegs fair value at $14 against a last close of $19.96, so the market price currently sits well above that estimate, even after accounting for a discount rate of 10.30% in the model.</p> <blockquote> <p><em>The analyst price target on Herbalife in our model has moved from US$12 to US$14, as analysts point to a recovery path supported by a healthier profit margin outlook, a slightly lower discount rate, and recent research highlighting ongoing business model improvements despite tempered revenue growth expectations and cautious sector valuations.</em></p> </blockquote> <p>Read the complete narrative.</p> <p>Want to see what is driving that higher margin outlook and upgraded fair value? The narrative focuses on future earnings power, steadier sales growth and a richer earnings multiple. Curious how those ingredients fit together and what assumptions sit underneath the discount rate and fair value change?</p> <p><strong>Result: Fair Value of $14 (OVERVALUED)</strong></p> <p>Have a read of the narrative in full and understand what's behind the forecasts.</p> <p>However, there is still a chance that stronger product momentum or progress in personalized wellness and technology platforms could support higher earnings power than this cautious view allows.</p> <p>Find out about the key risks to this Herbalife narrative.</p> <h2>Another view on Herbalife’s valuation</h2> <p>While the popular narrative sees Herbalife as 43% overvalued at $19.96 versus a $14 fair value, the SWS DCF model points in the other direction, with an estimated future cash flow value of $30.97, or about 35.5% above the current price. Which framework do you think better fits your own assumptions?</p> <p>Look into how the SWS DCF model arrives at its fair value.</p> <figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8127a7e9-e829-4439-9a7e-f7cb824f6737/chart/dcf/query-ZGF0ZT0yMDI2LTAyLTIz?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8127a7e9-e829-4439-9a7e-f7cb824f6737/chart/dcf/query-ZGF0ZT0yMDI2LTAyLTIz"/><figcaption>HLF Discounted Cash Flow as at Feb 2026</figcaption></figure><h2>Next Steps</h2> <p>After all this, are you feeling cautious or intrigued by Herbalife’s setup? Take a closer look at the full picture, weigh both sides, and move quickly to form your own stance with 3 key rewards and 2 important warning signs.</p> <h2>Looking for more investment ideas?</h2> <p>If Herbalife has sharpened your focus, do not stop here. Use this momentum to scan fresh ideas and keep your watchlist stocked with strong candidates.</p> <ul> <li>Target resilient potential by running your filters through our 85 resilient stocks with low risk scores that prioritize balance sheet strength and historically steadier risk profiles.</li> <li>Hunt for value opportunities with our 53 high quality undervalued stocks where solid fundamentals and conservative assumptions help you spot ideas that may be priced below their calculated worth.</li> <li>Spot opportunities others might skip by checking the screener containing 23 high quality undiscovered gems focused on companies with quality metrics that have not yet attracted wider attention.</li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data     and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your     financial situation. We aim to bring you long-term focused analysis driven by fundamental data.     Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.     Simply Wall St has no position in any stocks mentioned.</em></p><div><h3>Valuation is complex, but we're here to simplify it.</h3><p>Discover if Herbalife might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><p>Access Free Analysis</p></div></div></div>

FTXG

<p>Herbalife (HLF) has seen a significant share price rebound, currently at $19.96, with a 20% return over the past month and 67% over three months. Despite a 56% decline over five years, the stock shows a 140% return in the last year. Analysts suggest it may be overvalued at $19.96, with a fair value estimate of $14, while a DCF model indicates a potential value of $30.97. Investors are encouraged to consider both perspectives and explore additional investment opportunities.</p>

Simplywall

First Trust NASDAQ Food & Beverage

SPDR FD Consumer Staples

Assessing Herbalife (HLF) Valuation After A Sharp Multi‑Month Share Price Rebound